CClinicalTrials.gg
CompletedNCT05373563ObsQoR-11Updated Jan 26, 2023

Quality of Postpartum Cesarean Recovery Score Validity Reliability

An observational study in Failed VBAC (Vaginal Birth After Cesarean), sponsored by Ondokuz Mayıs University. Completed at 1 site in Turkey. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2023-01-26.

Sponsored by Ondokuz Mayıs University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
1
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

In order to provide the best care of patients after cesarean section, to help solve all their biopsychosocial problems in the recovery process, and to shorten the hospitalization period, it should be measured with appropriate measurement tools for various evaluations. The Scale of Post-cesarean Healing Quality You will provide in adapting the ObsQoR-11 questionnaire to Turkish.

Read the detailed description

In order to provide the best care of patients after cesarean section, to help solve all their biopsychosocial problems in the recovery process, and to shorten the hospitalization period, it should be measured with appropriate measurement tools for various evaluations. We will provide the Scale of Post-Cesarean Healing Quality in adapting the ObsQoR-11 questionnaire to Turkish.It is important to define well the recovery after cesarean section.

02

Conditions studied

  • Failed VBAC (Vaginal Birth After Cesarean)
03

In context

Lead sponsor

Ondokuz Mayıs University is the lead sponsor of 262 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Study study of 18 patients using large cesarean section.

Inclusion criteria

  • Must be Over 18 age,
  • Must be literate women,
  • Must be no neurological disease

Exclusion criteria

Exclusion Criteria:

  • Must be unwilling to participate in the study
  • Must be under 18 years old women
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
1 participant (actual)
Patient registry
No

Interventions

  • Procedurecesarean section women

    The test will be applied to women who have had a cesarean section and the Turkish validity and reliability of the scale will be determined according to the answers given.

06

What researchers measure

Primary outcomes

  1. Quality of Postpartum Cesarean Recovery Score validity reliability

    Measuring early recovery after cesarean section

    Time frame: July 2022-October 2022

  2. obstetric qualityof- recovery score (ObsQoR-11)

    Women were approached while in the postnatal ward 24 h after CS and asked to complete the ObsQoR-11K questionnaire and to choose a point in the 100-mm numeric rating scale (NRS) to evaluate global health status. Women rated each recovery item using an 11-point numerical Likert scale (0 = strongly negative; 10 = strongly positive). Global health status was measured using NRS indicated by a 100 mm line (0 = 'worst imaginable health status' and 'sad' face; 100 = 'best imaginable health status' and 'happy' face).

    Time frame: About six mount

07

Study locations

1 site
  • Samsun Health Directorate
    Samsun, Black Sea 55060, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 26, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05373563
Lead sponsor
Ondokuz Mayıs University
Responsible party
ümmühan kılıç (Principal Investigator, Ondokuz Mayıs University) — Principal investigator
First posted
May 13, 2022
Start date
Jul 24, 2022
Primary completion
Sep 5, 2022
Completion
Oct 2, 2022
Last update
Jan 26, 2023

Study contacts

Dilek Kıymaz,, PhD
principal investigator · Samsun Provincial Health Directorate
Esra Saraçoğlu, PhD
study chair · Samsun Provincial Health Directorate

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion